Patent ID: 7824710

Claim:
N-4-(1H-tetrazol-5-yl)phenyl-4-(1H-tetrazol-5-yl)benzamide disodium salt pentahydrate, Form A, characterized by the following X-ray powder diffraction pattern expressed in terms of 2θ, d-spacings, and relative intensities, when CuKa radiation is used 2θ d-value (Å) Intensity % 14.45 6.10 23 22.10 4.02 64 22.82 3.89 45 23.63 3.76 100 24.17 3.68 41 27.10 3.29 58 27.42 3.25 31 28.59 3.12 22 30.28 2.95 39 34.06 2.63 21.